Kjellman, N-I. M., and Larsson, Y. (1975) . Archives of Disease in Childhood, 50, 205 . Insulin release in cystic fibrosis. Early insulin response to rapid intravenous injection of glucose was studied in 7 cases of cystic fibrosis aged 8 months to 91 years. Plasma insulin was measured with a radioimmunological method. Blood glucose values were determined and the glucose disappearance rate (kG) calculated. In all children except the youngest one the early insulin response values were low compared with normal children. The kG-values were normal and correlated neither to the duration of clinical symptoms, nor to the patients' actual clinical condition measured by means of the Shwachman score. The explanation of the decreased insulin response is probably the progressive fibrosis of the pancreas. This may also explain the reported increased incidence of diabetes mellitus in cystic fibrosis. Comparison is made with the condition in pancreatic fibrosis in rabbits, produced through duct ligation.
In the extensive published reports on cystic fibrosis (CF) interest has been focused mainly on the exocrine function of the pancreas and on respiratory manifestations of the disease. Relatively little attention has been given to the function of the pancreatic islets. However, as the survival of patients with CF has improved and long-term follow-up studies have become possible, it has been maintained that the occurrence of diabetes mellitus in these patients is more than a chance occurrence. Thus, the incidence of diabetes was 10/1300 in the series reported by Rosan, Shwachman, and Kulczycki (1962) and 2/126 in the long-term study by Shwachman, Redmond, and Khaw, published in 1970. As the average incidence of onset of diabetes before the age of 15 years is 1-2/1000 (Sterky, 1963; Beardmore and Reid, 1966) , the reported figures for the incidence of diabetes among patients with CF are higher than if the two diseases had occurred independently.
Furthermore, some authors have found decreased carbohydrate tolerance and diminished insulin response to glucose administration in patients with CF (Milner, 1969; Handwerger et al., 1969 , Milunsky et al., 1971 . However, in these studies the early response of insulin release to glucose (ER) has not been analysed, although ER probably is the best indicator of the capacity of the ,3-cell to produce insulin (Cerasi and Luft, 1967a, b; Nosslin, Sterky, Received 5 August 1974. and Thorell, 1972) . For Carroll, Smith and Babson, (1971) . Plasma insulin was determined by radioimmunoassay using a commercial test kit (Pharmacia Phadebas). Glucose tolerance was calculated as the disappearance rate of glucose (kG) according to Ikkos and Luft (1957) . ER (Fig. 3 ) the youngest patient in the series, healthy children has been studied by Weber (1971) had considerably higher insulin levels and an ER (Fig. 4) . For the sake of comparison, the values of (1969) found that the majority of 61 children with CF had a lower insulin response to oral glucose than healthy children, though only 18 of these patients had decreased glucose tolerance. In the cases of Handwerger et al. (1969) , 13 of 31 CF patients had decreased oral glucose tolerance combined with delayed insulin response. In 9 of these cases intravenous tolerance tests again showed delayed insulin release. Milunsky et al. (1971) studied 15 CF patients with oral glucose tests and found the same type of insulinopenia without concomitant glucose intolerance. However, as both the diagnostic criteria and the methods used in these earlier reports differ considerably, a direct comparison between the results is not possible. The overall conclusion must be, however, that our study has confirmed that the capacity for insulin release is decreased in CF. CF may be considered as a predizbetic condition, as Cerasi and Luft (1967a, b) , Nosslin et al. (1972) , and others have shown that a poor early insulin response is a characteristic of the prediabetic state. Our findings are also in agreement with the clinical experience that overt or chemical diabetes is more common among CF patients than in the average population, particularly in cases of CF with a long observation time (Kaiser, Zuppinger, and Joss, 1970; Rosan et al., 1962; Shwachman et al., 1970) .
There are several possible explanations for the diminished insulin production in CF. One possibility might be that the gene for CF is linked to that for diabetes, but the absence of an increased incidence of CF among diabetics or in their families is against this hypothesis. Another explanation could be that the generalized dysfunction of secretory cells, characteristic of CF, also occurs in the 5-cells of the pancreas. However, as diabetes usually appears late in the course of CF (Gracey, 1971) , it seems more likely that it is a secondary rather than a primary manifestation of CF. Milner, in whose study the insulin response was poorer in oral than in intravenous glucose tolerance tests, has suggested that defects in the secretion of glucagonrelated hormones frcm specific intestinal mucosal cells might be of aetiological importance. This hypothesis does not seem to explain the poor insulin response to intravenous glucose, however. A low glucose tolerance could also be secondary to malnutrition, which is found in some CF patients.
Insulinopenia occurs, however, in CF patients with a good nutritional state and high Shwachman score figures. This was the case in our study. Handwerger et al. (1969) have suggested that the advanced structural alterations which are present in the exocrine parenchyma of the pancreas in CF also affects the islet function. The histological picture is characterized by a progressive fibrosis which usually involves the islet tissue as well and which might lead to an architectural disorganization of such an order of magnitude as to involve the blood supply and function of the islets. A decreased islet volume is a common feature in CF in analogy with the conditions in experimental pancreatic fibrosis secondary to ligation of the main pancreatic duct (Larsson, 1958; see Fig. 6 (Larsson, 1958) . A, untreated rabbits; B, rabbits with ligated pancreatic duct; C, alloxan-diabetic rabbits.
nesidioblastosis, which occurs both in healthy young children (Meissner, 1954) , experimental animals, and in patients with CF (Brown and Madge, 1971) . This might give temporary protection against or postpone the onset of diabetes. An analogy is the resistance towards the diabetogenic action of alloxan which is found in duct-ligated animals (Edstrom, 1972; Larsson, 1956; Walpole and Innes, 1946) . Nesidioblastosis seems to be more active in young subjects. In CF decreasing glucose tolerance and increasing incidence of overt diabetes with age might be explained by the fact that the relative protection against complete fibrotic islet destruction which nesidioblastosis provides during the early period of life, is gradually lost when the patient grows older and loses the capacity to form new islet cells.
4,
